Orbital myositis: a comprehensive review and reclassification

AA McNab - Ophthalmic Plastic & Reconstructive Surgery, 2020 - journals.lww.com
Purpose: Orbital myositis occurs in typical and atypical forms. This review summarizes and
updates the current state of knowledge of all forms of inflammation affecting extraocular …

Ocular side effects of bisphosphonates: a review of literature

NA Chartrand, CK Lau, MT Parsons… - Journal of Ocular …, 2023 - liebertpub.com
In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

Aminobisphosphonate‐associated orbital and ocular inflammatory disease

S Keren, I Leibovitch, R Ben Cnaan… - Acta …, 2019 - Wiley Online Library
Purpose Aminobisphosphonates may cause orbital/ocular inflammation. Awareness of the
clinical presentation and disease course is crucial. The purpose of this study was to analyse …

Pharmacologically induced uveitis

MEAA Elsayed, I Kozak - Survey of Ophthalmology, 2021 - Elsevier
Treatments of numerous systemic and local diseases of different etiologies may be
accompanied by an unwanted side effect in the form of uveitis. We inform readers about …

[HTML][HTML] Clinical impact of bisphosphonates in root canal therapy

MK AlRahabi, HM Ghabbani - Saudi medical journal, 2018 - ncbi.nlm.nih.gov
Bisphosphonates are stable structural analogs of pyrophosphate, which suppress the
activity of osteoclasts, leading to decreased bone resorption. They are essential medications …

Orbital myositis induced by alendronate: A case report

L Lefeuvre, A Caruso, E Biver… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Bisphosphonates are widely used, notably for osteoporosis
treatment. Their common side effects are well known. However, they can trigger less …

[HTML][HTML] Diffuse ocular and orbital inflammation after zoledronate infusion—case report and review of the literature

OC Umunakwe, D Herren, SJ Kim… - Digital Journal of …, 2017 - ncbi.nlm.nih.gov
Bisphosphonates have become a commonly used class of medications to treat osteoporosis
and other bone diseases. Zoledronate (zoledronic acid) can be dosed annually via …

Medication-associated orbital inflammation: A systematic review

T Ang, V Chaggar, JY Tong, D Selva - Survey of Ophthalmology, 2024 - Elsevier
We performed a comprehensive systematic review to identify medication-associated orbital
inflammation and to characterize its clinico-radiological features. We reviewed English …

[HTML][HTML] Acute Iridocyclitis associated with intravenous zoledronic acid: a case report

AR Ankireddypalli, S Sibley - Cureus, 2023 - ncbi.nlm.nih.gov
Bisphosphonates are widely used drugs for the management of osteoporosis. Intravenous
(IV) zoledronic acid (ZA) is frequently prescribed in cases of oral bisphosphonate …

Annual injection of zoledronic acid improves bone status in children with cerebral palsy and Rett syndrome

A Wiedemann, E Renard, M Hernandez… - Calcified Tissue …, 2019 - Springer
Osteoporosis is a common complication of cerebral palsy and Rett's syndrome. It is
responsible for multiple fractures, bone pain, and impaired quality of life. In case of Rett's …